Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from CVS Group plc ( (GB:CVSG) ) is now available.
CVS Group reported a 5.8% rise in revenue from continuing operations to £356.9m and a 3.9% increase in adjusted EBITDA to £67.7m for the six months to 31 December 2025, despite softer UK market conditions. Profit before tax fell 4.4% to £15.2m due to higher non-cash depreciation, acquisition-related costs, and exceptional items linked to the CMA inquiry and its move to the London Stock Exchange Main Market.
The group continued to expand in Australia, completing two practice acquisitions during the period and further deals post period-end, while investing £17.5m in relocations, refurbishments, and clinical equipment to boost capacity and standards of care. Its Main Market listing and expected FTSE 250 inclusion are set to improve access to capital and liquidity, supporting a strong acquisition pipeline and positioning CVS for medium- to long-term growth, even as UK consumer confidence remains weak and regulatory scrutiny continues.
The most recent analyst rating on (GB:CVSG) stock is a Hold with a £1480.00 price target. To see the full list of analyst forecasts on CVS Group plc stock, see the GB:CVSG Stock Forecast page.
Spark’s Take on GB:CVSG Stock
According to Spark, TipRanks’ AI Analyst, GB:CVSG is a Neutral.
CVS Group plc’s overall stock score is driven by strong financial performance and positive earnings call highlights, including revenue growth and successful acquisitions. However, the high P/E ratio and low dividend yield suggest overvaluation, while technical indicators point to potential overbought conditions. Challenges in the UK market and past cyber incidents also weigh on the score.
To see Spark’s full report on GB:CVSG stock, click here.
More about CVS Group plc
CVS Group plc is a UK-listed veterinary services group operating companion animal practices and related businesses, with a growing presence in Australia. The company focuses on clinical care, practice acquisitions, and investment in facilities, equipment, and technology, targeting long-term growth in veterinary healthcare markets.
Average Trading Volume: 567,346
Technical Sentiment Signal: Strong Buy
Current Market Cap: £975.2M
See more insights into CVSG stock on TipRanks’ Stock Analysis page.